APA (7th ed.) Citation

DL, H., GR, Z., DJ, Z., HQ, Z., C, W., RL, F., & CX, K. (2026). Immunohistochemistry-based risk stratification of upper tract urothelial carcinoma. Frontiers in oncology, 16, 1797142. https://doi.org/10.3389/fonc.2026.1797142

Chicago Style (17th ed.) Citation

DL, He, Zi GR, Zhang DJ, Zhong HQ, Wang C, Feng RL, and Ke CX. "Immunohistochemistry-based Risk Stratification of Upper Tract Urothelial Carcinoma." Frontiers in Oncology 16 (2026): 1797142. https://doi.org/10.3389/fonc.2026.1797142.

MLA (9th ed.) Citation

DL, He, et al. "Immunohistochemistry-based Risk Stratification of Upper Tract Urothelial Carcinoma." Frontiers in Oncology, vol. 16, 2026, p. 1797142, https://doi.org/10.3389/fonc.2026.1797142.